By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Added To NASDAQ Biotechnology Index 12/17/2015 7:20:24 AM
Egalet Submits New Drug Application To FDA For ARYMO ER (Morphine Sulfate) Extended-Release Tablets 12/15/2015 7:02:14 AM
Egalet Signs Agreement With Teva Pharmaceutical Industries To Commercialize SPRIX (ketorolac tromethamine) Nasal Spray In Select Geographies Outside The United States 12/14/2015 6:31:00 AM
Egalet Appoints Leading Experts To Scientific Advisory Board 12/9/2015 7:21:58 AM
Egalet Cuts Off Drug Partnership with Shionogi 12/4/2015 6:13:55 AM
Egalet Hires Paul Varki As Senior Vice President And General Counsel 11/16/2015 9:00:46 AM
Egalet Announces Issuance Of U.S. Patent Covering Guardian Technology And Its Abuse-Deterrent Product Candidates 11/12/2015 7:36:37 AM
Egalet Reports Third Quarter 2015 Financial Results And Provides Business Update 11/4/2015 9:46:39 AM
Egalet To Participate In Abuse-Deterrent Formulation And Investor Conferences And Will Co-Host A Category 1 Focus Group Meeting In November 10/28/2015 11:34:33 AM
Egalet To Host Conference Call And Webcast To Discuss Third Quarter 2015 Financial Results On November 4, 2015 10/21/2015 11:54:45 AM